Liposomal Methylene Blue 10mg - World First Liposoamal Highly variable absorption

Highly variable absorption

Human functional MRI studies have demonstrated that low-dose MB (0

and prevention of nocturnal muscle cramps that fragment sleep architecture

~72% oral bioavailability — MB is actually reasonably absorbed in standard form due to its small MW and partial lipophilicity

A drug older than aspirin that still outperforms every synthetic nootropic on the market for mitochondrial and neurological benefit

Liposomal Methylene Blue 10mg - World First Liposoamal Highly variable absorptionLIPOSOMAL METHYLENE BLUE 12MG The Mitochondrial Electron Carrier. 100 Years of Clinical History. Finally Biooptimised. WHAT IS METHYLENE BLUE? Methylene Blue (MB) is a phenothiazinium compound first synthesised in 1876. It was the first fully synthetic drug used in clinical medicine initially for malaria treatment and has since been approved by the FDA for methemoglobinaemia, cyanide poisoning, and ifosfamide induced encephalopathy. It has one of the